Johnson & Johnson (NYSE: JNJ) stock fell 1.5%, weighed by a hefty dip in sales of its blockbuster psoriasis treatment Stelara ...

Investing.com - Procter & Gamble (NYSE: PG) reported net sales in its fiscal second quarter that topped analysts’ estimates, ...

Barclays (LON:BARC) has downgraded STMicroelectronics NV (EPA:STMPA) to an “underweight” rating from its previous “equal ...

Abbott reported fourth-quarter earnings that met analyst expectations, but shares fell as revenue came in slightly below ...

The spin-off is planned to be completed by March 31, 2026, and is intended to be tax-free for both Aptiv and its shareholders. The transaction is subject to customary conditions, including approval ...